All results
1 results for impact
-
VX21-522-001
The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and…
- Ages
- 18 Years - 65 Years
- Sexes
- All